Results
|
2201.
|
Genetic Variants in HSD17B3, SMAD3, and IPO11 Impact Circulating Lipids in Response to Fenofibrate in Individuals With Type 2 Diabetes. [electronic resource] by
- Rotroff, Daniel M
- Pijut, Sonja S
- Marvel, Skylar W
- Jack, John R
- Havener, Tammy M
- Pujol, Aurora
- Schluter, Agatha
- Graf, Gregory A
- Ginsberg, Henry N
- Shah, Hetal S
- Gao, He
- Morieri, Mario-Luca
- Doria, Alessandro
- Mychaleckyi, Josyf C
- McLeod, Howard L
- Buse, John B
- Wagner, Michael J
- Motsinger-Reif, Alison A
Producer: 20190514
In:
Clinical pharmacology and therapeutics vol. 103
Availability: No items available.
|
|
2202.
|
Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells. [electronic resource] by
- Jeng, Long-Bin
- Velmurugan, Bharath Kumar
- Hsu, Hsi-Hsien
- Wen, Su-Ying
- Shen, Chia-Yao
- Lin, Chih-Hao
- Lin, Yueh-Min
- Chen, Ray-Jade
- Kuo, Wei-Wen
- Huang, Chih-Yang
Producer: 20180410
In:
Environmental toxicology vol. 33
Availability: No items available.
|
|
2203.
|
|
|
2204.
|
Long-Term Effects of Intensive Glycemic and Blood Pressure Control and Fenofibrate Use on Kidney Outcomes. [electronic resource] by
- Mottl, Amy K
- Buse, John B
- Ismail-Beigi, Faramarz
- Sigal, Ronald J
- Pedley, Carolyn F
- Papademetriou, Vasilios
- Simmons, Debra L
- Katz, Lois
- Mychaleckyj, Josyf C
- Craven, Timothy E
Producer: 20191202
In:
Clinical journal of the American Society of Nephrology : CJASN vol. 13
Availability: No items available.
|
|
2205.
|
|
|
2206.
|
|
|
2207.
|
Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes. [electronic resource] by
- Foucher, Christelle
- Rattier, Stephanie
- Flavell, David M
- Talmud, Philippa J
- Humphries, Steve E
- Kastelein, John J P
- Ayyobi, Amir
- Pimstone, Simon
- Frohlich, Jiri
- Ansquer, Jean-Claude
- Steiner, George
Producer: 20050504
In:
Pharmacogenetics vol. 14
Availability: No items available.
|
|
2208.
|
|
|
2209.
|
|
|
2210.
|
|
|
2211.
|
|
|
2212.
|
|
|
2213.
|
|
|
2214.
|
|
|
2215.
|
Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study. [electronic resource] by
- Oscarsson, Jan
- Önnerhag, Kristina
- Risérus, Ulf
- Sundén, Mattias
- Johansson, Lars
- Jansson, Per-Anders
- Moris, Linda
- Nilsson, Peter M
- Eriksson, Jan W
- Lind, Lars
Producer: 20191021
In:
Journal of clinical lipidology vol. 12
Availability: No items available.
|
|
2216.
|
|
|
2217.
|
|
|
2218.
|
|
|
2219.
|
Risk factors for statin-associated rhabdomyolysis. [electronic resource] by
- Schech, Stephanie
- Graham, David
- Staffa, Judy
- Andrade, Susan E
- La Grenade, Lois
- Burgess, Margaret
- Blough, David
- Stergachis, Andy
- Chan, K Arnold
- Platt, Richard
- Shatin, Deborah
Producer: 20070417
In:
Pharmacoepidemiology and drug safety vol. 16
Availability: No items available.
|
|
2220.
|
Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. [electronic resource] by
- Athyros, Vasilios G
- Mikhailidis, Dimitri P
- Didangelos, Triandafillos P
- Giouleme, Olga I
- Liberopoulos, Evangelos N
- Karagiannis, Asterios
- Kakafika, Anna I
- Tziomalos, Konstantinos
- Burroughs, Andrew K
- Elisaf, Moses S
Producer: 20060922
In:
Current medical research and opinion vol. 22
Availability: No items available.
|